Laboratorios RichmondC.I.F Balance Sheet Health
Financial Health criteria checks 0/6
Laboratorios RichmondC.I.F has a total shareholder equity of ARS23.0B and total debt of ARS93.7B, which brings its debt-to-equity ratio to 408.2%. Its total assets and total liabilities are ARS154.9B and ARS132.0B respectively. Laboratorios RichmondC.I.F's EBIT is ARS5.3B making its interest coverage ratio 1. It has cash and short-term investments of ARS823.0M.
Key information
408.2%
Debt to equity ratio
AR$93.70b
Debt
Interest coverage ratio | 1x |
Cash | AR$823.02m |
Equity | AR$22.95b |
Total liabilities | AR$131.95b |
Total assets | AR$154.90b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: RICH's short term assets (ARS31.4B) do not cover its short term liabilities (ARS36.3B).
Long Term Liabilities: RICH's short term assets (ARS31.4B) do not cover its long term liabilities (ARS95.6B).
Debt to Equity History and Analysis
Debt Level: RICH's net debt to equity ratio (404.7%) is considered high.
Reducing Debt: RICH's debt to equity ratio has increased from 38% to 408.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if RICH has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if RICH has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.